Bayer Monsanto
- All
- News
-
Monsanto Owner Bayer Says Glyphosate Is "Safe" After US Court Ruling
Bayer, the German owner of Monsanto, said Saturday that glyphosate is "safe" after a California jury ordered the US chemical giant to pay nearly $290 million for failing to warn a dying groundskeeper that the product, a component of weedkiller Roundup, might cause cancer.
-
CCI Approves Bayer-Monsanto Acquisition. Deal Details Here
German conglomerate Bayer is preparing to close its $62.5 billion takeover of Monsanto this quarter.
-
Competition Commission Seeks Fresh Application In Bayer-Monsanto Deal
The Bayer-Monsanto deal, announced in September 2016, would create create the world's biggest seed and pesticide firm.
-
Donald Trump's CEO Meetings Raise Ethics Questions
President-elect Donald Trump's meetings with CEOs seeking federal approval for major mergers are raising red flags for ethics lawyers concerned about the possible erosion of a firewall between the incoming White House and regulators reviewing those billion-dollar deals.
-
Monsanto Shareholders Back Bayer Deal, CEO Hopeful Of US Nod
If the deal closes, it will create a company commanding more than a quarter of the combined world market for seeds and pesticides in the fast-consolidating farm supplies industry.
-
Bayer's Open Offer Triggers Rally In Monsanto India Shares
Under the open offer, Bayer will acquire up to 44.88 lakh shares of Monsanto India from public shareholders at a price of Rs 2,481.60, which is nearly 4 per cent higher from Tuesday's closing price of Rs 2,392.1 on the National Stock Exchange.
-
Sensex Ends 16 points Lower Ahead Of US Fed Rate Decision
Among individual stocks, Monsanto India shares will in focus today as Bayer Group announced a mandatory offer to buy back up to 26 per cent additional stake in Monsanto India for over Rs 1,100 crore.
-
Bayer Launches Open Offer To Buy Up To 26% In Monsanto India
German pharma and chemical major Bayer group announced mandatory open offer to buy up to 26 per cent additional stake in the Monsanto India Ltd for over Rs 1,100 crore following its global deal to acquire US-based biotech major.
-
Bayer Ups Sales Targets For Top-Selling Drugs After Monsanto Deal
German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.
-
Bayer In $66 Billion Bet That Farmers Will Back Linked-Up Supplies
Bayer's $66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products.
-
Bayer Investor Royal London Backs Agreed Monsanto Offer
Bayer investor Royal London Asset Management said on Wednesday that it backed the agreed deal for US rival Monsanto, calling it "a great deal for Bayer shareholders".
-
Bayer Cropscience, Monsanto India Shares Rally On Parents' Merger
Bayer Cropscience is the Indian subsidiary of German-based Bayer AG and is engaged in the manufacturing of insecticides, fungicides and herbicides.
-
Bayer's Monsanto Acquisition To Face Politically Charged Scrutiny
As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production.
-
Bayer To Buy Monsanto In Record $66 Billion All-Cash Deal
Bayer said on Wednesday it won over Monsanto's management with a $128 per share offer in cash, worth about $66 billion including debt, to take over the global seed market leader.
-
Bayer Nears Acquisition Of Monsanto: Report
Monsanto's shares ended 0.8 percent lower at $106.10 in New York on Tuesday amid uncertainty over whether any agreed deal will clear antitrust hurdles.
-
Monsanto Owner Bayer Says Glyphosate Is "Safe" After US Court Ruling
Bayer, the German owner of Monsanto, said Saturday that glyphosate is "safe" after a California jury ordered the US chemical giant to pay nearly $290 million for failing to warn a dying groundskeeper that the product, a component of weedkiller Roundup, might cause cancer.
-
CCI Approves Bayer-Monsanto Acquisition. Deal Details Here
German conglomerate Bayer is preparing to close its $62.5 billion takeover of Monsanto this quarter.
-
Competition Commission Seeks Fresh Application In Bayer-Monsanto Deal
The Bayer-Monsanto deal, announced in September 2016, would create create the world's biggest seed and pesticide firm.
-
Donald Trump's CEO Meetings Raise Ethics Questions
President-elect Donald Trump's meetings with CEOs seeking federal approval for major mergers are raising red flags for ethics lawyers concerned about the possible erosion of a firewall between the incoming White House and regulators reviewing those billion-dollar deals.
-
Monsanto Shareholders Back Bayer Deal, CEO Hopeful Of US Nod
If the deal closes, it will create a company commanding more than a quarter of the combined world market for seeds and pesticides in the fast-consolidating farm supplies industry.
-
Bayer's Open Offer Triggers Rally In Monsanto India Shares
Under the open offer, Bayer will acquire up to 44.88 lakh shares of Monsanto India from public shareholders at a price of Rs 2,481.60, which is nearly 4 per cent higher from Tuesday's closing price of Rs 2,392.1 on the National Stock Exchange.
-
Sensex Ends 16 points Lower Ahead Of US Fed Rate Decision
Among individual stocks, Monsanto India shares will in focus today as Bayer Group announced a mandatory offer to buy back up to 26 per cent additional stake in Monsanto India for over Rs 1,100 crore.
-
Bayer Launches Open Offer To Buy Up To 26% In Monsanto India
German pharma and chemical major Bayer group announced mandatory open offer to buy up to 26 per cent additional stake in the Monsanto India Ltd for over Rs 1,100 crore following its global deal to acquire US-based biotech major.
-
Bayer Ups Sales Targets For Top-Selling Drugs After Monsanto Deal
German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.
-
Bayer In $66 Billion Bet That Farmers Will Back Linked-Up Supplies
Bayer's $66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products.
-
Bayer Investor Royal London Backs Agreed Monsanto Offer
Bayer investor Royal London Asset Management said on Wednesday that it backed the agreed deal for US rival Monsanto, calling it "a great deal for Bayer shareholders".
-
Bayer Cropscience, Monsanto India Shares Rally On Parents' Merger
Bayer Cropscience is the Indian subsidiary of German-based Bayer AG and is engaged in the manufacturing of insecticides, fungicides and herbicides.
-
Bayer's Monsanto Acquisition To Face Politically Charged Scrutiny
As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production.
-
Bayer To Buy Monsanto In Record $66 Billion All-Cash Deal
Bayer said on Wednesday it won over Monsanto's management with a $128 per share offer in cash, worth about $66 billion including debt, to take over the global seed market leader.
-
Bayer Nears Acquisition Of Monsanto: Report
Monsanto's shares ended 0.8 percent lower at $106.10 in New York on Tuesday amid uncertainty over whether any agreed deal will clear antitrust hurdles.
